Cancer Research Cancer Epigenetics  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 28, 198-206, February 1, 1968]
© 1968 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sinclair, W. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sinclair, W. K.

The Combined Effect of Hydroxyurea and X-rays on Chinese Hamster Cells in Vitro1

Warren K. Sinclair

Division of Biological and Medical Research, Argonne National Laboratory, Argonne, Illinois 60439

Hydroxyurea inhibits DNA synthesis in Chinese hamster cells and is selectively toxic for cells actually in DNA synthesis (i.e., in S phase) at the time of exposure to the drug. Synchronized cells in G1 inhibited from entering S by hydroxyurea show a complex response to X-radiation. Cells become steadily more sensitive for a period of about 4 hr and then recover about a normal G1 sensitivity in approximately a further 4 hr. They never achieve the high survival level normally found for uninhibited cells in late S, but they will reach this level quite rapidly if the hydroxyurea is removed prior to exposure. The sensitization is, therefore, completely reversible. Hydroxyurea has no effect if present only during exposure at room temperature. Additional sensitization is obtained if the drug is present after exposure which increases for a period of about 4 hr. This postirradiation sensitization is independent of the time in the cycle at which irradiation takes place.

These results with synchronized populations enable the effects of hydroxyurea on asynchronous populations to be predicted. The most sensitive condition occurs when irradiation is given about 4 hr after the administration of hydroxyurea and the drug is kept on subsequently.

The results indicate that hydroxyurea in combination with X-rays can be a most effective toxic agent for Chinese hamster cells. If these results are applicable to in vivo situations, combination therapy with hydroxyurea given systemically and X-rays delivered locally to tumors may be most effective. However, in view of some of the problems in tumor control that cannot be evaluated in vitro, experiments with suitable animal tumor systems are needed.

1 This work was supported by the U. S. Atomic Energy Commission.

Received 5/29/67. Accepted 10/ 3/67.




This article has been cited by other articles:


Home page
JCOHome page
D. S. Shewach and T. S. Lawrence
Antimetabolite Radiosensitizers
J. Clin. Oncol., September 10, 2007; 25(26): 4043 - 4050.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. A. Barker, W. E. Burgan, D. J. Carter, D. Cerna, D. Gius, M. G. Hollingshead, K. Camphausen, and P. J. Tofilon
In vitro and In vivo Radiosensitization Induced by the Ribonucleotide Reductase Inhibitor Triapine (3-Aminopyridine-2-Carboxaldehyde-Thiosemicarbazone).
Clin. Cancer Res., May 1, 2006; 12(9): 2912 - 2918.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. J. Ostruszka and D. S. Shewach
The Role of Cell Cycle Progression in Radiosensitization by 2',2'-Difluoro-2'-deoxycytidine
Cancer Res., November 1, 2000; 60(21): 6080 - 6088.
[Abstract] [Full Text]


Home page
NEJMHome page
P. G. Rose, B. N. Bundy, E. B. Watkins, J. T. Thigpen, G. Deppe, M. A. Maiman, D. L. Clarke-Pearson, and S. Insalaco
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
N. Engl. J. Med., April 15, 1999; 340(15): 1144 - 1153.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
M. C. Chamberlain and V. A. Levin
Adjuvant Chemotherapy for Primary Lymphoma of the Central Nervous System
Arch Neurol, October 1, 1990; 47(10): 1113 - 1116.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1968 by the American Association for Cancer Research.